These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31436766)
1. Bifunctional supramolecular prodrug vesicles constructed from a camptothecin derivative with a water-soluble pillar[5]arene for cancer diagnosis and therapy. Sun G; He Z; Hao M; Xu Z; Hu XY; Zhu JJ; Wang L Chem Commun (Camb); 2019 Sep; 55(73):10892-10895. PubMed ID: 31436766 [TBL] [Abstract][Full Text] [Related]
2. GSH-Responsive supramolecular nanoparticles constructed by β-d-galactose-modified pillar[5]arene and camptothecin prodrug for targeted anticancer drug delivery. Liu X; Shao W; Zheng Y; Yao C; Peng L; Zhang D; Hu XY; Wang L Chem Commun (Camb); 2017 Jul; 53(61):8596-8599. PubMed ID: 28718478 [TBL] [Abstract][Full Text] [Related]
3. Supramolecular chemotherapeutic drug constructed from pillararene-based supramolecular amphiphile. Wu D; Li Y; Shen J; Tong Z; Hu Q; Li L; Yu G Chem Commun (Camb); 2018 Jul; 54(59):8198-8201. PubMed ID: 29975382 [TBL] [Abstract][Full Text] [Related]
4. Construction of drug-drug conjugate supramolecular nanocarriers based on water-soluble pillar[6]arene for combination chemotherapy. Shao W; Liu X; Sun G; Hu XY; Zhu JJ; Wang L Chem Commun (Camb); 2018 Aug; 54(68):9462-9465. PubMed ID: 30083687 [TBL] [Abstract][Full Text] [Related]
5. Enzyme-responsive fluorescent camptothecin prodrug/polysaccharide supramolecular assembly for targeted cellular imaging and in situ controlled drug release. Zhang YH; Zhang YM; Sheng X; Wang J; Liu Y Chem Commun (Camb); 2020 Jan; 56(7):1042-1045. PubMed ID: 31868189 [TBL] [Abstract][Full Text] [Related]
6. Orthogonal Design of a Water-Soluble Tian X; Zuo M; Niu P; Velmurugan K; Wang K; Zhao Y; Wang L; Hu XY ACS Appl Mater Interfaces; 2021 Aug; 13(31):37466-37474. PubMed ID: 34314153 [TBL] [Abstract][Full Text] [Related]
7. A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts. Endo M; Miwa M; Ura M; Tanimura H; Taniguchi K; Miyazaki Y; Ohwada J; Tsukazaki M; Niizuma S; Murata T; Ozawa S; Suda H; Ogawa K; Nanba E; Nagao S; Shimma N; Yamada-Okabe H Cancer Chemother Pharmacol; 2010 Jan; 65(2):363-71. PubMed ID: 19495753 [TBL] [Abstract][Full Text] [Related]
8. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related]
9. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy. Wang Z; Wu H; Liu P; Zeng F; Wu S Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754 [TBL] [Abstract][Full Text] [Related]
10. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
11. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols. Hu Y; Zeng F Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642 [TBL] [Abstract][Full Text] [Related]
12. A supramolecular hybrid material constructed from pillar[6]arene-based host-guest complexation and ZIF-8 for targeted drug delivery. Yang K; Yang K; Chao S; Wen J; Pei Y; Pei Z Chem Commun (Camb); 2018 Aug; 54(70):9817-9820. PubMed ID: 30109320 [TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy. Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873 [TBL] [Abstract][Full Text] [Related]
14. pH-responsive supramolecular vesicles based on water-soluble pillar[6]arene and ferrocene derivative for drug delivery. Duan Q; Cao Y; Li Y; Hu X; Xiao T; Lin C; Pan Y; Wang L J Am Chem Soc; 2013 Jul; 135(28):10542-9. PubMed ID: 23795864 [TBL] [Abstract][Full Text] [Related]
15. A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent. Whang CH; Yoo E; Hur SK; Kim KS; Kim D; Jo S Chem Commun (Camb); 2018 Aug; 54(65):9031-9034. PubMed ID: 30047958 [TBL] [Abstract][Full Text] [Related]
16. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery. Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750 [TBL] [Abstract][Full Text] [Related]
17. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy. Leu YL; Chen CS; Wu YJ; Chern JW J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity. Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251 [TBL] [Abstract][Full Text] [Related]
19. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery. Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976 [TBL] [Abstract][Full Text] [Related]
20. Orthogonal Design of Supramolecular Prodrug Vesicles via Water-Soluble Pillar[5]arene and Betulinic Acid Derivative for Dual Chemotherapy. Sun G; Zuo M; Xu Z; Wang K; Wang L; Hu XY ACS Appl Bio Mater; 2022 Jul; 5(7):3320-3328. PubMed ID: 35486958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]